Insider Trading & Ownership - Myers Scott Dunseth

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Myers Scott Dunseth
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-04-12
Purchase
2023-04-12
7:05 pm
Viridian Therapeutics Inc.VRDNMyers Scott Dunseth
Chief Executive Officer
4,000$25.37$101,479259,500
(Direct)
View
2023-03-13
Purchase
2023-03-13
4:06 pm
Viridian Therapeutics Inc.VRDNMyers Scott Dunseth
Chief Executive Officer
5,500$29.15$160,324255,500
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-11-13
Option Award
2024-11-13
5:46 pm
N/A
N/A
Zentalis Pharmaceuticals Inc.ZNTLMyers Scott Dunseth
Director
260,192$0260,192
(Direct)
View
2024-05-23
Option Award
2024-05-28
8:32 pm
N/A
2031-05-22
DYNAVAX TECHNOLOGIES CORPDVAXMyers Scott Dunseth
Director
27,857$047,946
(Direct)
View
2024-03-11
Disposition
2024-03-11
5:24 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPMyers Scott Dunseth
Director
29,298$00
(Direct)
View
2024-01-01
Option Award
2024-01-03
4:30 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPMyers Scott Dunseth
Director
2,048$022,666
(Direct)
View
2023-11-27
Option Award
2023-11-28
4:26 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPMyers Scott Dunseth
Director
5,000$020,618
(Direct)
View
2023-11-13
Disposition
2023-11-15
5:16 pm
N/A
2033-01-01
Cartesian Therapeutics Inc.RNACMyers Scott Dunseth
Director
87,500$0.930
(Direct)
View
2023-11-13
Disposition
2023-11-15
5:16 pm
N/A
2029-06-13
Cartesian Therapeutics Inc.RNACMyers Scott Dunseth
Director
120,000$00
(Direct)
View
2023-10-01
Option Award
2023-10-02
5:36 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPMyers Scott Dunseth
Director
5,797$015,618
(Direct)
View
2023-07-01
Option Award
2023-07-06
6:34 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPMyers Scott Dunseth
Director
35,634$098,215
(Direct)
View
2023-06-22
Option Award
2023-06-23
4:36 pm
N/A
2033-06-21
Harpoon Therapeutics Inc.HARPMyers Scott Dunseth
Director
46,000$046,000
(Direct)
View
2023-05-26
Option Award
2023-05-31
5:35 pm
N/A
2030-05-25
DYNAVAX TECHNOLOGIES CORPDVAXMyers Scott Dunseth
Director
27,857$042,589
(Direct)
View
2023-04-01
Option Award
2023-04-04
5:06 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPMyers Scott Dunseth
Director
34,925$062,581
(Direct)
View
2023-02-06
Option Award
2023-02-07
6:55 pm
N/A
2033-02-06
Viridian Therapeutics Inc.VRDNMyers Scott Dunseth
Chief Executive Officer
1,250,000$01,250,000
(Direct)
View
2023-01-02
Option Award
2023-01-04
5:06 pm
N/A
2033-01-01
SELECTA BIOSCIENCES INCSELBMyers Scott Dunseth
Director
87,500$087,500
(Direct)
View
2022-06-22
Option Award
2022-06-24
6:48 pm
N/A
2032-06-21
Harpoon Therapeutics Inc.HARPMyers Scott Dunseth
Director
20,334$020,334
(Direct)
View
2022-05-26
Option Award
2022-05-27
5:01 pm
N/A
N/A
DYNAVAX TECHNOLOGIES CORPDVAXMyers Scott Dunseth
Director
20,893$020,893
(Direct)
View
2022-01-03
Option Award
2022-01-05
4:34 pm
N/A
2032-01-02
SELECTA BIOSCIENCES INCSELBMyers Scott Dunseth
Director
40,000$040,000
(Direct)
View
2021-11-17
Disposition
2021-11-19
1:33 pm
N/A
2031-05-03
Trillium Therapeutics Inc.TRILMyers Scott Dunseth
Director
67,000$00
(Direct)
View
2021-10-25
Option Award
2021-10-26
4:22 pm
N/A
2031-10-25
Harpoon Therapeutics Inc.HARPMyers Scott Dunseth
Director
10,167$010,167
(Direct)
View
2021-10-19
Option Award
2021-10-21
5:04 pm
N/A
N/A
DYNAVAX TECHNOLOGIES CORPDVAXMyers Scott Dunseth
Director
55,714$055,714
(Direct)
View

Ownership
2021-10-21
5:03 pm
N/A
N/A
DYNAVAX TECHNOLOGIES CORPDVAXMyers Scott Dunseth
Director
0$00
(Direct)
View
2021-05-04
Option Award(A)
2021-05-14
8:03 pm
N/A
2031-05-03
Harpoon Therapeutics Inc.HARPMyers Scott Dunseth
Director
10,167$010,167
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:56 pm
N/A
2031-05-03
Harpoon Therapeutics Inc.HARPMyers Scott Dunseth
Director
10,167$010,167
(Direct)
View
2021-05-03
Option Award
2021-05-05
4:16 pm
N/A
2031-05-03
Trillium Therapeutics Inc.TRILMyers Scott Dunseth
Director
67,000$067,000
(Direct)
View
2021-03-30
Option Award
2021-04-01
6:31 pm
N/A
2031-03-29
SELECTA BIOSCIENCES INCSELBMyers Scott Dunseth
Director
40,000$040,000
(Direct)
View
2020-11-16
Disposition
2020-11-17
3:42 pm
N/A
N/A
AMAG PHARMACEUTICALS INC.AMAGMyers Scott Dunseth
President & CEO
1,000,000$00
(Direct)
View
2020-06-19
Option Award
2020-06-23
4:47 pm
N/A
2030-06-18
SELECTA BIOSCIENCES INCSELBMyers Scott Dunseth
Director
20,000$020,000
(Direct)
View
2020-05-28
Option Award
2020-06-01
9:50 pm
N/A
2030-05-27
Harpoon Therapeutics Inc.HARPMyers Scott Dunseth
Director
10,167$010,167
(Direct)
View
2020-04-28
Option Award
2020-04-30
5:02 pm
N/A
2030-04-28
AMAG PHARMACEUTICALS INC.AMAGMyers Scott Dunseth
President & CEO
1,000,000$01,000,000
(Direct)
View
2019-12-23
Option Award
2019-12-26
5:29 pm
2019-12-23
2024-12-23
SELECTA BIOSCIENCES INCSELBMyers Scott Dunseth
Director
19,704$0.125100,549
(Direct)
View
2019-12-23
Option Award
2019-12-26
5:29 pm
N/A
N/A
SELECTA BIOSCIENCES INCSELBMyers Scott Dunseth
Director
39,409$1.46100,549
(Direct)
View
(A) Indicate amendment filing.